Impact of Obesity on the Efficacy of Endocrine Therapy With Aromatase Inhibitors

Summary

To see the impact of obesity on the efficacy of adjuvant endocrine therapy with aromatase inhibitors in postmenopausal patients with early breast cancer in terms of: i) Locoregional recurrence ii) Distant metastases iii) Disease-free survival iv) Overall survival

Timeline

Start

2012-01

Primary completion

2020-01

Completion

2020-06

Drugs

Indications